FREE Webinar
Tuesday, May 12, 2020
2:30 - 4:00 PM, Eastern Standard Time
Cancer vaccines target unique antigens on tumors, including overexpressed healthy proteins or virus-derived proteins. Each individual tumor is unique, carrying its own distinguishing antigens, which can complicate the cancer vaccine development process. To better characterize, identify, and understand the dynamic interactions between the immune system and cancer cell antigens, researchers can turn to advanced flow cytometry and live-cell imaging technologies. This webinar, brought to you by The Scientist and sponsored by Sartorius, will present new research and developments in the cancer vaccine field, and delve into the intricacies of target discovery and vaccine development.
Topics to be covered
- Developing breast cancer vaccines with dendritic cell tumor fusions
- Boosting immunity with cancer vaccines: A focus on breast and ovarian cancer immunology
Meet the Speakers:
David E. Avigan, MD
Professor of Medicine
Beth...
Mary L. (Nora) Disis, MD
Helen B. Slonaker Endowed Professor for Cancer Research
American Cancer Society Clinical Research Professor
Professor, Medicine, Adjunct Professor Pathology and Obstetrics and Gynecology, University of Washington
Director, UW Medicine Cancer Vaccine Institute
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
